Effects of progesterone and anti-progestin (mifepristone) treatment on proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3

  • Authors:
    • Raffaèle Fauvet
    • Charlotte Dufournet Etienne
    • Christophe Poncelet
    • Annie-France Bringuier
    • Gérard Feldmann
    • Emile Daraï
  • View Affiliations

  • Published online on: April 1, 2006     https://doi.org/10.3892/or.15.4.743
  • Pages: 743-748
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The study examined the effects of various progesterone and mifepristone concentrations on the proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3. OVCAR-3 cells were incubated with progesterone and mifepristone at concentrations ranging from 10−3 to 10−9 M. Proliferation and apoptosis were studied by means of inverted optical microscopy, DAPI staining, and crystal violet assay. Immunoblotting was used to study the regulation of the apoptosis-related proteins, bcl-2, caspase-3 and PARP, after incubation with various reagents. OVCAR-3 cell density was increased by progesterone concentrations of 10−5 M or less, and decreased by 10−3 M progesterone. DAPI staining showed no apoptotic bodies. Mifepristone concentrations of 10−3 and 10−4 M reduced the OVCAR-3 cell density. Immunoblotting showed PARP cleavage in the presence of mifepristone 10−4 M. Caspase-3 and bcl-2 expression was reduced by mifepristone 10−4 and 10−7 M. These results suggest that progesterone has a paradoxical effect on OVCAR-3 cell proliferation, stimulating it at low concentrations and inhibiting it at high concentrations, potentially through a caspase-independent non-apoptotic death pathway. Mifepristone seems to inhibit OVCAR-3 cell proliferation by down-regulating bcl-2 and up-regulating caspase-3 activity. These preliminary results suggest that progesterone and mifepristone have beneficial effects in ovarian cancer.

Related Articles

Journal Cover

April 2006
Volume 15 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Fauvet R, Etienne CD, Poncelet C, Bringuier A, Feldmann G and Daraï E: Effects of progesterone and anti-progestin (mifepristone) treatment on proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3. Oncol Rep 15: 743-748, 2006
APA
Fauvet, R., Etienne, C.D., Poncelet, C., Bringuier, A., Feldmann, G., & Daraï, E. (2006). Effects of progesterone and anti-progestin (mifepristone) treatment on proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3. Oncology Reports, 15, 743-748. https://doi.org/10.3892/or.15.4.743
MLA
Fauvet, R., Etienne, C. D., Poncelet, C., Bringuier, A., Feldmann, G., Daraï, E."Effects of progesterone and anti-progestin (mifepristone) treatment on proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3". Oncology Reports 15.4 (2006): 743-748.
Chicago
Fauvet, R., Etienne, C. D., Poncelet, C., Bringuier, A., Feldmann, G., Daraï, E."Effects of progesterone and anti-progestin (mifepristone) treatment on proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3". Oncology Reports 15, no. 4 (2006): 743-748. https://doi.org/10.3892/or.15.4.743